Switzerland· 65570006

Jardiance Met

A metformin and empagliflozin product containing empagliflozinum, metformini hydrochloridum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BD20

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedJardiance MetATCA10BD20REGISTER NO.65570006PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Metformin and empagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD20 (metformin and empagliflozin), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Metformin and empagliflozin · ATC A10BD20

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
empagliflozinum, metformini hydrochloridum
Manufacturer
—
Country
Switzerland (CH)
ATC code
A10BD20
ATC class
Metformin and empagliflozin
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680655700062
    2x 90 Stk
    CHF 157.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Metformin and empagliflozin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and empagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Empagliflozin/Metformin Hcs
  • Belgium · Empagliflozine/Metformine Hcl Hcs
  • Bulgaria · Empafel Met 5 Mg/850 Mg, Емпафел Мет
  • Cyprus · Empagliflozin/Metformin Tad
  • Czechia · Mempoglyn
  • Denmark · Empagliflozin/Metformin Krka
  • Estonia · Mempoglyn
  • Spain · Empagliflozina/Metformina Krka
  • Greece · Mempoglyn
  • Croatia · Mempoglyn
  • Hungary · Mempoglyn
  • Ireland · Empagliflozin/Metformin Krka
  • Iceland · Appref, Empagliflozin-Metformin Adalvo
  • Liechtenstein · Synjardy
  • Lithuania · Mempoglyn
  • Luxembourg · Empagliflozin/Metformin Hcl Ab
  • Latvia · Mempoglyn
  • Malta · Appref, Empagliflozin-Metformin Adalvo
  • Netherlands · Appref, Empagliflozine/Metformine Hcl Hcs
  • Norway · Empagliflozin/Metformin Krka, Synjardy
  • Portugal · Empagliflozina + Metformina Aurobindo, Empagliflozina + Metformina Generis
  • Romania · Mempoglyn
  • Slovenia · Emameten, Empagliflozin/Metformin Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db08c253-972d-4002-95cb-489a2269bf10
GET /v1/drugs/db08c253-972d-4002-95cb-489a2269bf10?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "empagliflozinum 5 mg + metformini hydrochloridum 1000 mg",
  "valid_from": "2016-01-01",
  "limitations": "[{\"description\":\"<!DOCTYPE html>\\n<html>\\n<head></head>\\n<body>\\n<p>Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche zus&auml;tzlich zu di&auml;tetischen Massnahmen und k&ouml;rperlicher Aktivit&auml;t keine ad&auml;quate Blutzuckerkontrolle erzielen und<br>- mit der maximal tolerierten Dosis Metformin oder<br>- mit der maximal tolerierten Dosis Metformin zus&auml;tzlich zu einem Sulfonylharnstoff und/oder einem Insulin behandelt werden und dabei keine ad&auml;quate Blutzuckerkontrolle erzielen oder<br>- in Kombination mit einem GLP1-1-Analogon oder<br>- bereits mit Empagliflozin und Metformin als separate Tabletten behandelt werden.<br>Es wird maximal eine Tagesdosierung von 10 mg Empagliflozin verg&uuml;tet.</p>\\n</body>\\n</html>\",\"costApproval\":null,\"indication\":\"20401.01\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-09-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 5/1000mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2016-01-01",
  "self_retention_pct": 10
}

See everything about metformin and empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.